Connecting existing downstream steps delivers the value of continuous bioprocessing, says executive Jon Coffman at BioProcess ...

The physics that dictate this field’s timelines remain unforgiving. Radiopharmaceuticals cannot be inventoried the way ...

Autolomous CEO Alexander Seyf explains why collaboration, not competition, could unlock progress in cell and gene therapy ...

Reformatting historical data and getting scientists to agree on how to generate it are among the biggest hurdles in hybrid ...

Ultimately, the discussion suggested that progress will come not from replacing CHO wholesale, but from pairing earlier, ...